Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_assertion type Assertion NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_head.
- NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_assertion description "[Although parallel assessment of PML-RAR alpha and RAR alpha-PML can enhance minimal residual disease detection in APL, this study demonstrates that treatment strategies involving determination of PCR status post-consolidation, even using RAR alpha-PML in addition to the more conventional PML-RAR alpha assay will fail to identify all patients at risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_provenance.
- NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_assertion evidence source_evidence_literature NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_provenance.
- NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_assertion SIO_000772 8558940 NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_provenance.
- NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_assertion wasDerivedFrom befree-2016 NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_provenance.
- NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_assertion wasGeneratedBy ECO_0000203 NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_provenance.